COMMUNIQUÉS West-GlobeNewswire

FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER™ (amantadine) extended-release tablets for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions in Adults

19/02/2018 - 19:00

BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) [...]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at Two Upcoming Healthcare Investor Conferences

19/02/2018 - 19:00

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., Feb. 19, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), today announced they will be presenting at [...]

Sanofi: Disclosure of trading in own shares

19/02/2018 - 17:41

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/5f7e1210-1c87-4466-91ad-c83329e827dd

Sanofi : Déclaration des transactions sur actions propres

19/02/2018 - 17:41

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/41c2db5d-2733-40d9-9be1-05b72b1bafd8

Ossur Hf : Transactions in relation to share buyback program

19/02/2018 - 17:01

Announcement from Össur hf. No. 11/2018 Reykjavík, 19 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Transactions under Novozymes’ stock buyback program

19/02/2018 - 16:04

Please read the full announcement in the attached PDF http://prlibrary-eu.nasdaq.com/Resource/Download/fe173723-e6ca-4eb1-9177-48696a6c841e

Notice to convene annual general meeting 2018 of GN Store Nord

19/02/2018 - 14:16

Please find enclosed notice of GN Store Nord A/S’ annual general meeting 2018, including the complete proposals for the agenda. For further information, please contact: Investors and analysts Peter Justesen VP – [...]

The American Health Council Names Gilberto Alvarado, MSN, CNP, FNP-BC, BSN, RN to Board of Nurses

19/02/2018 - 14:00

NEW YORK, Feb. 19, 2018 (GLOBE NEWSWIRE) -- Gilberto “Gil” Alvarado, MSN, CNP, FNP-BC, BSN, RN is named to the American Health Council’s Board of Nurses for his impeccable contributions to the nursing field, both in a [...]

Alder BioPharmaceuticals® to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial and Operating Results

19/02/2018 - 14:00

BOTHELL, Wash., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

19/02/2018 - 13:01

FIT Biotech Oy Company release February 19, 2018 at 2:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Novo Nordisk A/S - Share repurchase programme

19/02/2018 - 12:12

Bagsværd, Denmark, 19 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Notice of Annual General Meeting

19/02/2018 - 09:04

Valby, Denmark, 2018-02-19 09:04 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 19 February 2018 – Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Tuesday, 20 March 2018 at 10:00 am The [...]

Oasmia Pharmaceutical’s Docecal program achieves significant development milestone

19/02/2018 - 08:30

Oasmia Pharmaceutical AB announces that all patients have been treated in the two ongoing studies with Docecal in metastatic breast cancer. Uppsala, Sweden, February 19, 2018 – Oasmia Pharmaceutical AB (NASDAQ: OASM), a [...]

Bone Therapeutics SA completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB®

19/02/2018 - 07:01

Press release Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB ® Efficacy and safety results expected in mid-2019 Promising interim efficacy and safety data already reported [...]

Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB®

19/02/2018 - 07:01

Communiqué de presse Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB ® Résultats d'efficacité et de sécurité attendus mi-2019 Données [...]

MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California

19/02/2018 - 00:00

LA JOLLA, Calif., Feb. 18, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology

18/02/2018 - 00:30

SAN DIEGO, Feb. 17, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the [...]

AnaptysBio Presents Updated Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting

17/02/2018 - 23:00

SAN DIEGO, Feb. 17, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]

TLC Files Registration Statement for Proposed Initial Public Offering

17/02/2018 - 10:06

TAIPEI, Taiwan, Feb. 17, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel [...]